Incorporation of an internal ribosome entry site (IRES) into
Introduction
While gene therapy of simple Mendelian disorders often requires the substitution of only a single therapeutic gene, the treatment of complex disorders and infectious diseases may necessitate the delivery of multiple therapeutic genes into the cell. Complex disorders like cancer often involve mutations in multiple cellular gatekeeper and caretaker genes, among others, and a combination approach simultaneously targeting multiple defective genes would be expected to be more effective than any single-gene substitution strategy. Similarly, therapies targeted towards infectious diseases such as HIV-1 (human immunodeficiency virus) also necessitate approaches that block multiple different steps of the viral replication pathway simultaneously to minimize the emergence of resistant strains of the virus. Even for single gene defects, it is often necessary to incorporate another gene, eg a selectable marker for sustained expression of the therapeutic gene within cells. Hence, the ability to efficiently coexpress multiple genes is an important consideration in the design of gene therapy vectors.
There are generally three ways in which two or more genes can be co-expressed. Firstly, separate promoters can be used to drive expression of different genes in the same vector to achieve coordinated maintenance of gene copy number within cells. However, such constructs often suffer from the problem of promoter attenuation, whereby the 3Ј gene is suppressed upon selection of the 5Ј gene and vice versa. 1 Secondly, two different genes can be fused together in-frame to produce a chimeric protein, guaranteeing the expression of both genes simultaneously. Although some functional fusion proteins have been successfully expressed, 2,3 eg the adenosine deaminase-MDR1 fusion protein, this strategy may not work for all combinations of proteins, some of which could result in protein misfolding or mistargeting. The third strategy for co-expression involves the design of bicistronic constructs, in which two genes separated by an internal ribosome entry site (IRES) sequence are expressed as a single transcriptional cassette (or bicistronic transcript) under the control of a common upstream promoter. The intervening IRES sequence functions as a ribosome-binding site for efficient cap-independent internal initiation of translation. Such a design enables coupled transcription of both genes, followed by cap-dependent initiation of translation of the first gene and IRES-directed cap-independent translation of the second gene. Coordinate gene expression is thus ensured in this configuration.
IRES sequences have been found in the 5' untranslated
Gene Therapy region (UTR) of several viral and mammalian genes. Viral IRESes have been utilized in gene therapy vectors for the co-expression of multiple genes, with the IRES from the encephalomyocarditis virus (EMCV) being commonly employed. However, it was observed that EMCV IRES-mediated translation of the downstream gene was much less efficient compared with the cap-dependent translation of the upstream gene. [4] [5] [6] Furthermore, it has been reported that the order of arrangement of the genes on the transcript greatly influences the efficiency of viral IRES-dependent translation. 7 IRES sequences that have been identified in mammalian genes include those of the immunoglobulin heavy chain binding protein (BIP), 8 eukaryotic initiation factor 4G (EIF4G), 9 c-myc proto-oncogene (MYC), 10 and vascular endothelial growth factor (VEGF). 11, 12 Thus far, they have not been utilized in gene therapy vectors for the coexpression of multiple genes. While most of the IRESes from viral genes are approximately 450 nucleotides in length, IRESes from mammalian genes can range in size from approximately 100 bp to more than 1 kb. Unlike viral IRESes, mammalian IRESes often serve as recognition sites for translational regulatory factors, thereby mediating post-transcriptional regulation of gene expression. Examples include IRES-mediated translation of VEGF mRNA, which remains efficient even under unfavorable hypoxic conditions when overall translation is reduced, 11 and stress-modulated translation of FGF-2.
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The respective IRESes located at the 5'UTR of these genes have been suspected to be responsible for this regulation.
The potentially regulatable feature of such mammalian IRESes could be exploited for gene therapy of specific diseases such as cancer.
In this article, we explored the effectiveness of IRESes located within human genes in mediating multiple-gene co-expression, by comparing their translation efficiency to that of the EMCV IRES. Our results indicate that three of the four human IRESes tested were between five-to more than 100-fold better than the EMCV IRES in mediating downstream gene expression in KB-3-1 cells, with the EIF4G IRES consistently demonstrating the greatest increase in all cell lines tested. The fourth IRES, derived from the VEGF gene, did not differ significantly from EMCV IRES in mediating downstream gene expression in KB-3-1 cells under normoxic conditions, but was significantly more efficient under hypoglycemic conditions.
Results
Mammalian IRESes generally exhibit higher expression efficiency compared with EMCV IRES in KB-3-1 cells KB-3-1 cells were transfected with bicistronic constructs containing either a human IRES or the EMCV IRES, and normalized GAL expression results are shown in Figure  1 . Vectors containing either of three human IRESes expressed GAL more efficiently than pCatEMCGal containing the EMCV IRES, with enhancement ranging between five-(P Ͻ 0.05) to greater than 100-fold (P Ͻ 0.05). The greatest enhancement of downstream GAL expression over EMCV IRES was observed with the EIF4G IRES. Only the VEGF IRES did not show a significant difference compared with EMCV IRES. 
pHaMDR). Table below shows the fold difference in downstream GAL gene expression of BIP, EIF4G, MYC and VEGF IRES constructs compared with EMCV IRES construct. Student's t test was carried out to determine the significance of the difference between the downstream GAL gene expression of the various cellular IRESes and that of the EMCV IRES. The P-value of the Student's t test is indicated in the table. NS, not significantly different.

EIF4G IRES exhibits significantly higher expression efficiency than EMCV IRES in multiple cell lines
The performance of an IRES in one cell-type may not be similar to its performance in another cell line, as it has been reported that the IRES from the mouse glial and testis-specific homeobox protein gene Gtx can mediate better downstream gene expression than the EMCV IRES by three-to greater than 60-fold depending on cell line. 14 To examine if the significantly higher downstream gene expression mediated by the EIF4G IRES observed in KB-3-1 cells is cell type-specific, the constructs containing the EMCV and EIF4G IRESes were each transfected into three additional cell lines. The cell lines tested were the human embryonic kidney cell line HEK 293, the murine neuroblastoma cell line N2a, and the human hepatoma cell line HepG2. The results demonstrate that the superior performance of the EIF4G IRES is not only restricted to KB-3-1 cells but was also observed in the other three cell lines ( Figure 2 ). In fact, the EIF4G IRES mediates better downstream gene expression in the other three cell lines compared with KB-3-1.
Variable performance of the BIP, MYC and VEGF IRES in different cell lines
To determine how the other mammalian IRESes performed in different cell lines, constructs comprising the EMCV, BIP, MYC and VEGF IRESes were each transfected into two additional cell lines, N2a and HEK 293 and normalized downstream gene expression was determined. As shown in Figure 3 , although the BIP IRES mediated approximately seven-fold better downstream gene expression than the EMCV IRES in KB-3-1 cells (P Ͻ 0.05), it is not significantly different from EMCV IRES 
Control (CTRL) represents cells transfected with an irrelevant DNA (pHaMDR). The inserted chart shows the normalized downstream GAL activity of EMCV IRES at a different Y-axis scale from the main chart. Table below shows the fold difference in downstream GAL gene expression of EIF4G IRES construct compared with EMCV IRES construct in the different cell lines. Student's t test was carried out to determine the significance of the difference between the downstream GAL gene expression of the EIF4G IRESes and that of the EMCV IRES in each cell line. The P-value of the Student's t test is indicated in the table. NS, not significantly different.
Figure 3 Normalized GAL reporter activity in different cell lines transfected with EMCV, BIP, MYC and VEGF IRES constructs. In addition to KB-3-1 cells, N2a and 293 cells were transfected with each of the indicated bicistronic vector. Results are expressed as mean and standard deviation of the normalized downstream GAL gene expression from several independent transfections as indicated in the tables below. The GAL activity was normalized against the CAT activity. Control (CTRL) represented cells transfected with an irrelevant DNA (pHaMDR). Table below shows the fold difference in downstream GAL gene expression of BIP, MYC and VEGF IRES constructs compared with the EMCV IRES construct in each of the cell lines tested. Student's t test was carried out to determine the significance of the difference between the downstream GAL gene expression of the BIP, MYC and VEGF IRES and that of the EMCV IRES in each cell line. The P-value of the Student's t test is indicated in the table. NS, not significantly different.
Gene Therapy in either N2a and HEK 293 cells. The MYC IRES was found to perform better than the EMCV IRES in KB-3-1, as well as N2a cells (P Ͻ 0.05), but not in HEK 293 cells (Figure 3 ). In contrast, the VEGF IRES was not significantly different from the EMCV IRES in mediating downstream gene expression in KB-3-1 and N2a cells and was inferior (P Ͻ 0.05) to the EMCV IRES in HEK 293 cells (Figure 3) .
Full-length, but not truncated VEGF IRES mediates higher expression efficiency under hypoglycemic conditions
Although three of the four human IRESes tested showed significant improvements (P Ͻ 0.05) in mediating downstream gene expression compared with the EMCV IRES in KB-3-1 cells, the exception was the VEGF IRES ( Figure  1 ). The 5'UTR of the VEGF gene is approximately 1 kb in length, and contains 2 IRESes (A and B) which are thought to cooperate synergistically to effect efficient downstream translation. 12 However, it has been reported that a truncated version of the mouse Vegf IRES containing the 5' end of the Vegf 5'UTR and a portion of IRES A is better than a full-length 1 kb fragment containing both IRES A and IRES B, in mediating downstream gene expression. 11 We therefore compared the performances of the human full-length (VEGF IRES) and truncated (V163 IRES) versions against the EMCV IRES in KB-3-1 cells. The results show the V163 IRES to be capable of mediating significantly better downstream gene expression than either the complete VEGF IRES (P Ͻ 0.05) or EMCV IRES (P Ͻ 0.05) (Figure 4 when CAP-dependent translation is compromised. We examined the efficiency of EMCV IRES, VEGF IRES, and V163 IRES in mediating downstream gene expression under a different, but analogous stress condition, hypoglycemia, in which KB-3-1 cells transfected with each IRES construct was incubated for 12 h in medium lacking glucose before harvesting and expression analysis. As shown in Figure 4 , while the EMCV IRES function remains largely unaffected when glucose is withdrawn, there is a significant enhancement of downstream gene expression in KB-3-1 cells carrying the full-length VEGF IRES under hypoglycemic conditions (P Ͻ 0.05). Conversely, the ability of the truncated V163 IRES to mediate downstream gene expression is significantly decreased under hypoglycemic conditions compared with normal culture conditions (P Ͻ 0.05).
Discussion
The incorporation of IRESes within gene therapy vectors facilitates efficient co-expression of multiple genes. [4] [5] [6] 15, 16 This feature has great relevance for the gene therapy of complex disorders and infectious diseases, as well as for long-term expression of therapeutic genes. However, the efficiency of viral IRESes such as the commonly used EMCV IRES has been found to be unsatisfactory. [4] [5] [6] Mammalian IRESes can be exploited for the efficient co-expression of multiple genes as they have advantages over EMCV IRES. The use of human IRESes in gene therapy vectors minimizes possible undesirable effects associated with viral sequences. Also, unlike viral IRESes, some mammalian IRESes preferentially express in specific cell types and are regulatable, potentially allowing for the design of vectors tailored to the treatment of diseases that affect specific cell types (eg PDGF IRES for treatment of diseases affecting platelets or megakaryocytes), or to the treatment of solid tumors (eg VEGF IRES which is hypoxia-regulatable). In addition, while the viral IRES is about 450 bp in length, mammalian IRESes range in size from under 100 bp 14 to approximately 1 kb. 11 For example, the smaller mammalian IRESes from the GTX (glial and testis-specific homeobox protein) or BIP genes may be useful for incorporation into vectors with limited packaging capacity, such as those derived from AAV (adeno-associated virus) or SV40 (simian virus 40).
Our results show that most of the human IRESes that we tested facilitate the expression of the downstream gene more efficiently than EMCV IRES in KB-3-1 cells (Figure 1 ). In particular, the EIF4G IRES mediated very high downstream gene expression in three other tested cell lines (Figure 2) . However, more variable results were observed for the other human IRESes, which showed lower enhancement of downstream gene expression than the EMCV IRES (Figure 3) . Although the BIP IRES is approximately seven-fold better (P Ͻ 0.05) than the EMCV IRES in mediating downstream gene expression in KB-3-1 cells, it is not significantly better than the EMCV IRES in two other cell lines tested. The MYC IRES is significantly better than the EMCV IRES in mediating downstream gene expression in KB-3-1 (P Ͻ 0.05) and N2a (P Ͻ 0.05) cells, but not in HEK 293 cells. In contrast, the VEGF IRES is inferior to the EMCV IRES in mediating downstream gene expression in HEK 293 cells (P Ͻ 0.05), but not significantly different from the EMCV IRES in KB-3-1 or N2a cells. These variable observations could be due to the availability of different factors in the different cell lines that can either activate or repress the different IRES functions. Hence, these results highlight the importance of testing the performance of each IRES in the cell type of interest before it can be implemented for incorporation into gene therapy vector for the co-expression of genes in that particular cell type.
Like the EMCV IRES, the BIP IRES contains a Y-type stem-loop structure. 17 Unlike the EMCV IRES, however, the BIP IRES has an additional hairpin immediately before the authentic AUG start codon and does not have a polypyrimidine tract (PPT). 17 Although the La autoantigen and PPT binding protein (PTB) have been reported to be important for efficient EMCV IRES function, 18, 19 these two proteins do not seem to interact with BIP IRES. 8 A more complex secondary RNA structure and the absence of cryptic translation start sites were observed in the MYC IRES compared with the EMCV IRES. 20 Unlike the MYC and BIP IRESes, however, the EIF4G mRNA is structurally similar to the EMCV IRES, and contains cryptic AUG start sites and a functional PPT that is required for activity. 9, 21 However, unlike the EMCV IRES, the PPT of the EIF4G IRES cannot be replaced by purines. 9 Another feature that distinguishes the EIF4G IRES from the EMCV IRES is the ability of EIF4G to initiate translation when the AUG start is variably spaced from the PPT, 9 whereas the spacing between the PPT and the initiator AUG in the EMCV IRES is critical for downstream gene expression. 22, 23 These features of the EIF4G IRES could perhaps account for its superior efficiency in mediating downstream gene expression.
Of the four human IRESes tested, only the VEGF IRES did not differ significantly from the EMCV IRES in expression efficiency in KB-3-1 and N2a cells and is inferior to EMCV IRES in HEK 293 cells (Figure 3) . The VEGF 5'UTR is very unique in that it contains two independent IRESes, A and B, acting together to facilitate efficient initiation of translation at the same AUG codon.
12 IRES A is approximately 300 bp in length and located immediately upstream from the initiator AUG, thus allowing for ribosome binding and translation initiation without scanning. 12 IRES B is located upstream of IRES A (Figure 5c ) and is approximately 400 bp in length. It contains a predicted stem-loop structure bearing the GNRA motif characteristic of picornavirus IRESes and a PPT. 11, 12, 24 Different proteins bind to each of the two IRESes, with very few proteins binding to IRES A, the majority of proteins including PTB binding to IRES B. However, whereas PTB is important for the function of the EMCV IRES, its binding to IRES B of VEGF is not correlated with IRES activity. 12 The occurrence of two different IRESes in VEGF suggests the interesting possibility of an additional level of Gene Therapy regulation of VEGF expression at the translational level, since VEGF plays a central role in angiogenesis with complex regulation. A truncated form of the mouse Vegf IRES containing a short segment of the 5' end of the 5'UTR and 3' end of the IRES A was found to mediate more efficient downstream gene expression than the entire 5'UTR. 11 This truncated Vegf IRES was also predicted to fold to a Y-type stem-loop structure. 11 It was also reported that gene expression downstream of both the full length and the truncated mouse Vegf IRES could be maintained even under hypoxic conditions when CAP-dependent translation was compromised. 11 Hence, we explored the feasibility of using a truncated form of the human VEGF IRES to improve downstream gene expression. We also examined the performance of the full-length and truncated forms of human VEGF IRES under hypoglycemia, another stress condition. In this report, we demonstrated that the truncated form of the human VEGF IRES (V163) is capable of mediating better downstream gene expression than either full-length VEGF-IRES (P Ͻ 0.05) or EMCV IRES (P Ͻ 0.05) ( Figure  4 ) under normal conditions. Interestingly, unlike the EMCV IRES or V163 IRES, full-length VEGF IRES was able to mediate more efficient downstream gene expression (P Ͻ 0.05) in the absence of glucose than in the presence of glucose (Figure 4 ). In fact, there is a significant decrease in gene expression mediated by the V163 IRES in cells under hypoglycemia compared with normoxic conditions (P Ͻ 0.05). These observations suggest that although a minimum of 163 bp is sufficient to mediate efficient downstream gene expression from the VEGF IRES, the other regions of the VEGF IRES are necessary for the regulation of gene expression under stress conditions. This is likely related to the different factors that bind to the two different IRESes of VEGF that are involved in regulating its translation. 12 Hence, the VEGF IRES may have potential applications in the expression of therapeutic genes within the core of solid tumors, which are often hypoxic or hypoglycemic.
In summary, there is great potential in using mammalian IRESes for the co-expression of multiple genes. It remains to be determined if the observations made here are applicable in different gene therapy vector systems including viral (eg retroviral) and non-viral systems. 25 As it has been reported that the nature of the upstream gene influences the translation efficiency of the viral IRES, 7 it would also be important to determine if our observations are also applicable when different therapeutic genes are introduced upstream and downstream of these cellular IRESes. The applicability of other cellular as well as artificial IRESes 26 for the co-expression of multiple genes for gene therapy can also be explored.
Materials and methods
Construction of bicistronic vectors
An EMCV IRES bicistronic vector, pCatEMCGal, was created by cloning the chloramphenicol acetyl transferase gene (CAT) from pCEP4CAT (Invitrogen, Groningen, The Netherlands), and the ␤-galactosidase gene (GAL) from pCMVbeta (Clontech, Palo Alto, CA, USA), into pIRESneo (Clontech, GenBank Accession No. U89673) upstream and downstream of EMCV IRES, respectively ( Figure 6 ). In this construct, the AUG start codon of the downstream gene is 45 bp 3' to the IRES. The construct was confirmed by restriction analysis.
IRESes from the BIP, EIF4G, MYC and VEGF genes were amplified from human genomic DNA by the polymerase chain reaction (PCR) using gene-specific primers (Figure 5a ). Two versions of VEGF IRES were tested, ã 1 kb full-length fragment containing both IRES A and IRES B, 12 and a 163 bp truncated version V163 IRES containing 31 nucleotides of the 5'end of the 5'UTR and part of IRES A (Figure 5b and c) . All amplified human IRES fragments were blunt-end cloned into the NaeI and SmaI sites of pCatEMCGal in place of the EMCV IRES (see Figure 6 ). Clones were confirmed to be correct by sequencing and restriction analysis.
Cell transfections KB-3-1 (a subclone of HELA), HepG2 (a human hepatoma cell line), HEK293 (a human embryonic kidney cell line), and N2a (a murine neuroblastoma cell line) were cultured in DMEM supplemented with 10% fetal bovine serum and incubated at 37°C in the presence of 5% CO 2 . Cells in six-well dishes at 50-70% confluence were transfected in duplicate with 12 g plasmid DNA via calcium phosphate co-precipitation. 27 Thirty-six hours after transfection, the cells were washed two to three times with PBS and fed with either glucose-containing or glucosefree DMEM media. Cells were harvested 12 h later for protein, CAT and GAL reporter assays. Cells transfected with irrelevant DNA were used as negative control. Each experiment was repeated several times to ensure reproducibility of results.
GAL and CAT reporter assays GAL expression was quantitated in a kinetic enzyme assay 28 using Chlorophenol red-␤-D-galactopyranoside (CPRG) (Roche Molecular Biochemicals, Indianapolis, IN, USA) as substrate and monitored at 1-min intervals for 60 min at 570 nm using the SpectraMax Plus microplate spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). CAT expression was quantitated using a commercially available CAT ELISA kit (Roche Molecular Biochemicals).
The relative efficiency of each IRES was obtained by normalizing the level of downstream reporter gene product against the level of upstream reporter gene product. For each experiment, results were accepted only when transfection efficiencies of the different constructs were similar, as determined by comparable expression levels of the upstream gene in the various constructs.
Statistical analysis
The significance of the difference between different groups of data was determined by Student's t test. TwoGene Therapy sample equal variance t test was applied for data which do not have significantly different standard deviations between the two groups as determined by F test, while two-sample unequal variance t test was used for data with large differences in standard deviation.
